Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 2 months ago

Indications

Seemaquine is used for the treatment of malaria, as well as its prophylaxis and suppression. It is also used in the treatment of amoebic hepatitis and abscess, in the treatment of discoid and systemic lupus erythematosus, and in the treatment of rheumatoid arthritis.

⚠️ Always consult a registered physician before taking any medicine.

Pharmacology

Chloroquine phosphate belongs to the 4-aminoquinoline class of antimalarial and amoebicidal medicines. It is used to suppress and clinically cure malaria caused by susceptible strains of *Plasmodium falciparum*, *P. ovale*, *P. vivax*, and *P. malariae*. It works quickly against the blood stages of the parasite (blood schizonts) and also has some activity against gametocytes.

The exact way it acts against blood schizonts is not fully understood, but it is thought to raise the pH within intracellular vesicles of the malaria parasite, which disrupts the parasite's ability to digest haemoglobin. It is also thought to interfere with the parasite's synthesis of nucleoproteins.

When taken by mouth, chloroquine is absorbed rapidly and almost completely from the gastrointestinal tract. Absorption is likewise rapid after intramuscular or subcutaneous injection. Around 55% of the chloroquine circulating in the blood is bound to plasma proteins.

Pregnancy & Breastfeeding

Pregnancy: Chloroquine is best avoided in pregnancy. However, if a pregnant woman develops malaria, her physician may still prescribe it for prevention or treatment when the benefit to her is judged to outweigh any possible risk.

Breastfeeding: Chloroquine passes into breast milk and could cause serious harm to a nursing infant. The mother and her physician should therefore decide whether to stop breastfeeding or to stop the medicine, weighing how important the drug is for the mother's own health.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

Dosage Reference

⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.

Adults: Doses are usually expressed in terms of chloroquine base. As a general guide, chloroquine base 300 mg is roughly equivalent to chloroquine phosphate 500 mg. For treating an acute attack of malaria: Adults and children are given a total of 25 mg of chloroquine base per kg body weight spread over 3 days. This can be done in different ways. One approach is 10 mg per kg first, followed 6 to 8 hours later by 5 mg per kg, then 5 mg per kg daily for the next 2 days. Another approach is 10 mg per kg daily for the first 2 days, then 5 mg per kg on the 3rd day. Adult doses are sometimes given as fixed amounts rather than by body weight: 600 mg first, followed 6 to 8 hours later by 300 mg, then 300 mg daily for the next 2 days. For malaria prophylaxis: Adults take an oral dose equal to 300 mg of chloroquine base every 7 days, starting about one week before exposure, continuing throughout exposure, and for at least 4 weeks afterward. Children are usually given a weekly oral dose of 5 mg per kg body weight. For hepatic amoebiasis: Adults take 600 mg of base daily for 2 days, then 300 mg of base daily for at least 2 to 3 weeks. This is usually combined with an effective intestinal amoebicide. For discoid and systemic lupus erythematosus: The suggested oral dose is 150 mg of base daily, reduced gradually once symptoms are under control. For rheumatoid arthritis: Adults take 150 mg of base daily, and some clinicians recommend limiting treatment to 10 months of each year. Children are given 3 mg per kg body weight of base daily. For managing photoallergic reactions: Adults take 150 to 300 mg of base daily during periods of intense light exposure. Children are given 3 mg per kg body weight. For porphyria cutanea tarda: When chloroquine was first used for this condition, at doses of 150 mg to 600 mg of base per day for 4 to 7 days, it caused severe, life threatening toxic hepatitis. Using a low dose of 75 mg of base 2 to 3 times per week for 6 to 18 months can avoid this effect and lead to remission.

Side Effects & Interactions

Side Effects

No side-effect data recorded yet.